One Trial to Evaluate the Safety, Tolerability and Efficacy of JCXH-213 in Patients With r/r B-NHL

Clinical trial NCT06618313 · RECRUITING

Trial details

NCT number: NCT06618313
Sponsor: Beijing GoBroad Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

B-Cell Non-Hodgkin Lymphoma-Recurrent B-Cell Non-Hodgkin Lymphoma-Refractory

Start date: 2025-03-27
Primary completion: 2026-08-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.